HORIBA Medical is proud to announce that its Yumizen H500 benchtop hematology analyzer has won the Best New Clinical Instrumentation Award for 2022 at…

Chase the Case #23 showcases a case obtained with HORIBA's new Yumizen H500 analyzer, specifically designed for small mid-size laboratories. Discover…

The latest issue features thalassemia, one of the Hemoglobinopathies. Discover how it occurs, the categories, population patterns, and more. This…

On the occasion of HORIBA Medical's 40th anniversary, on July 7, 2023, Atsushi Horiba received the medal of Honorary Citizen of the City of…

Chase the Case #22 introduces a case from India, a female patient aged 48, diagnosed with Acute Monoblastic Leukemia (AML). See how it was indicated…

In June 2023, HORIBA Medical became a corporate member of the International Council for Standardization in Haematology (ICSH), one of the most…

Continuing from the last issue, this issue will introduce hemoglobinopathies in more detail. Learn about their inheritance and one of the most common…

Chase the Case #21 discusses a male patient aged 57, diagnosed with Chronic Lymphocytic Leukemia (CLL). Look at the DIFF scattergram of this case…

The 36th issue of QSP Newsletter discusses hemoglobinopathy, a group of blood disorders that affect red blood cells in addition to the monthly digital…

The 20th issue of Chase the Case discusses a case of a male aged 64 with lymphoproliferative syndrome. See how the Yumizen H2500 hematology analyzer…